Trospium Chloride; Xanomeline Tartrate Patent Expiration
Trospium Chloride; Xanomeline Tartrate was first introduced by Bristol-Myers Squibb Co
Trospium Chloride; Xanomeline Tartrate Patents
Given below is the list of patents protecting Trospium Chloride; Xanomeline Tartrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cobenfy | US10925832 | Compositions and methods for treatment of disorders ameliorated by muscarinic receptor activation | Sep 27, 2039 | Bristol-myers |
| Cobenfy | US10933020 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Sep 27, 2039 | Bristol-myers |
| Cobenfy | US11452692 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Sep 27, 2039 | Bristol-myers |
| Cobenfy | US11471413 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Sep 27, 2039 | Bristol-myers |
| Cobenfy | US11890378 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Sep 27, 2039 | Bristol-myers |
| Cobenfy | US10238643 | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation | Jul 21, 2030 | Bristol-myers |
| Cobenfy | US10265311 | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation | Jul 21, 2030 | Bristol-myers |
| Cobenfy | US10369143 | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation | Jul 21, 2030 | Bristol-myers |
| Cobenfy | US10369144 | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation | Jul 21, 2030 | Bristol-myers |
| Cobenfy | US10695339 | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation | Jul 21, 2030 | Bristol-myers |
Trospium Chloride; Xanomeline Tartrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List